Group structure
6 companies in 3 countries
Canada4
Italy1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loading your page…
Loading your page…
6 companies in 3 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1–25 of 45
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ÁGUA PARA INJETÁVEIS | Água para injetáveis | Brazil | Authorised | 2023 |
| ANFO B | Anfotericina b | Brazil | Authorised | 2026 |
| anfotericina B | Anfotericina b | Brazil | Authorised | 2026 |
| BIMANEXTCollirio, soluzione | Bimatoprost | Italy | Authorised | |
| CLARITROMICINA | Clarithromycin | Brazil | Authorised | 2024 |
| CLORETO DE SÓDIO 0,9% | Cloreto | Brazil | Authorised | 2023 |
| cloridrato de dexmedetomidina | Dexmedetomidine | Brazil | Authorised | 2026 |
| cloridrato de gencitabina | Gencitabina | Brazil | Authorised | 2019 |
| cloridrato de melfalana | Melphalan | Brazil | Authorised | 2025 |
| DEXAVISIONCollirio, soluzione | Desametasone | Italy | Authorised | |
| ENOKSA | Enoxaparin | Brazil | Authorised | 2025 |
| GLICOSE | Glicose | Brazil | Authorised | 2025 |
| IRGASSCollirio, soluzione in contenitore monodose | Bromfenac | Italy | Authorised | |
| lactato de milrinona | Milrinone | Brazil | Authorised | 2024 |
| MANITOL | Mannitol | Brazil | Authorised | 2025 |
| mesilato de rasagilina | Rasagiline | Brazil | Authorised | 2021 |
| micofenolato de mofetila | Mycophenolate mofetil | Brazil | Authorised | 2023 |
| TEBARATCollirio, soluzione | Azelastine | Italy | Authorised | |
| TIMBRIXCollirio, soluzione | Brimonidine, Timolol | Italy | Authorised | |
| VISPAR | Parecoxib | Brazil | Authorised | 2026 |
| voriconazol | Voriconazole | Brazil | Authorised | 2023 |
| ACTONEL | Risedronate | Brazil | Cancelled | 2021 |
| AM CAPS30 mg / cap + 150 mcg / cap + 0.2 mg / cap + 10 mg / cap + 1250 unit / cap + 0.75 mg / cap + 3 mcg / cap + 0.90 mg / cap + 1 mg / cap + 100 unit / cap · Capsule | Ascorbic acid, Biotin, Folic acid, Nicotinamide, Vitamin a, Vitamin b1, Vitamin b12, Vitamin b2, Vitamin b6, Vitamin d | Canada | Cancelled | 1998 |
| AM CAPS30 mg + 150 mcg + 0.20 mg + 10 mg + 50 mcg + 2500 unit + 0.75 mg + 5 mcg + 0.85 mg + 1 mg + 200 unit + 15 unit · Capsule | Ascorbic acid, Biotin, Folic acid, Nicotinamide, Selenium, Vitamin a, Vitamin b1, Vitamin b12, Vitamin b2, Vitamin b6, Vitamin d, Vitamin e | Canada | Cancelled | |
| AWESOME ANIMALS50 mg / tab + 150 mcg / tab + 125 mg / tab + 5 mg / tab + 0.2 mg / tab + 0.075 mg / tab + 50 mg / tab + 10 mg / tab + 0.8 mg / tab + 2500 unit / tab + 3 mcg / tab + 1 mg / tab + 1 mg / tab + 200 unit / tab + 15 unit / tab · Tablet | Ascorbic acid, Biotin, Calcium, D-pantothenic acid, Folic acid, Iodine, Magnesium, Nicotinamide, Vitamin b1, Vitamin a, Vitamin b12, Vitamin b2, Vitamin b6, Vitamin d, Vitamin e | Canada | Cancelled | 1998 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 25 | 16 | 9 | CompaniesAll medicines |
| Canada | 15 | 0 | 15 | CompaniesAll medicines |
| Italy | 5 | 5 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.